Neurology (73 companies · 62 conditions)

Conditions

Amyotrophic Lateral Sclerosis 13 Rare Multiple Sclerosis 13 Parkinson's Disease 13 Alzheimer's Disease 12 Major Depressive Disorder 9 Myasthenia Gravis 8 Rare Duchenne Muscular Dystrophy 7 Rare Bipolar Disorder 5 Generalized Anxiety Disorder 5 Huntington's Disease 5 Rare Schizophrenia 5 Epilepsy 4 Friedreich's Ataxia 4 Rare Frontotemporal Dementia 4 Rare Lewy Body Dementia 4 Myotonic Dystrophy 4 Rare Multiple System Atrophy 3 Rare Post-Traumatic Stress Disorder 3 Rett Syndrome 3 Rare Substance Use Disorder 3 Angelman Syndrome 2 Rare Attention Deficit Hyperactivity Disorder 2 Autism Spectrum Disorder 2 Dravet Syndrome 2 Rare Facioscapulohumeral Muscular Dystrophy 2 Rare Progressive Supranuclear Palsy 2 Rare Spinal Cord Injury 2 Stiff Person Syndrome 2 Rare Acute Pain 1 Aneurysmal Subarachnoid Hemorrhage 1 Anorexia Nervosa 1 Charcot-Marie-Tooth Disease Type 2S 1 Rare Chronic Inflammatory Demyelinating Polyneuropathy 1 Rare CLN2 Batten Disease 1 Rare Cocaine Use Disorder 1 Delayed Sleep Phase Disorder 1 Dementia-Related Psychosis 1 Essential Tremor 1 Fragile X Syndrome 1 Rare Giant Axonal Neuropathy 1 Rare GNE Myopathy 1 Rare Guillain-Barré Syndrome 1 Infantile Spasms 1 Rare Insomnia 1 Ischemic Stroke 1 Jet Lag Disorder 1 Lennox-Gastaut Syndrome 1 Rare Limb-Girdle Muscular Dystrophy 1 Rare Migraine 1 Motion Sickness 1 Narcolepsy 1 Rare Neuromyelitis Optica Spectrum Disorder 1 Rare Non-24-Hour Sleep-Wake Disorder 1 Non-Fluent Variant Primary Progressive Aphasia 1 Rare Primary Periodic Paralysis 1 Rare Smith-Magenis Syndrome 1 Rare Spinal Bulbar Muscular Atrophy 1 Rare Spinal Muscular Atrophy 1 Rare Spinocerebellar Ataxia 1 Rare Tourette Syndrome 1 Tuberous Sclerosis Complex 1 Rare X-Linked Adrenoleukodystrophy 1 Rare

Companies

Ticker	Company	Therapeutic areas	In Neurology	Lead stage	Programs
ACIU	AC Immune	Neurology Rare	9	Phase 3	10
ABOS	Acumen Pharmaceuticals	Neurology	4	Phase 2	4
ACET	Adicet Bio	ImmunologyNeurology+2 Rare	1	Phase 1	8
ATHE	Alterity Therapeutics	Neurology Rare	2	Phase 2	2
ALT	Altimmune	GI/HepatologyMetabolic+1	1	Phase 3	3
AMLX	Amylyx Pharmaceuticals	MetabolicNeurology Rare	1	Phase 3	5
ANNX	Annexon	HematologyNeurology+2 Rare	3	Phase 3	6
ARVN	Arvinas	NeurologyOncology Rare	3	Approved	12
ATAI	Atai Beckley	Neurology	5	Phase 2	5
AUTL	Autolus Therapeutics	HematologyImmunology+3 Rare	1	Approved	12
CABA	Cabaletta Bio	DermatologyImmunology+2 Rare	1	Phase 2	8
CAPR	Capricor Therapeutics	Infectious DiseaseNeurology Rare	1	NDA Submitted	2
RNAC	Cartesian Therapeutics	ImmunologyNeurology+1 Rare	1	Phase 3	4
CRVO	CervoMed	Neurology Rare	4	Phase 2	4
CING	Cingulate	Neurology	1	NDA Submitted	1
CLNN	Clene	Neurology Rare	3	Phase 3	5
CGTX	Cognition Therapeutics	Neurology	2	Phase 2	2
CMPS	COMPASS Pathways	Neurology	3	NDA Submitted	3
HELP	Cybin	Neurology	3	Phase 3	3
CYDY	CytoDyn	NeurologyOncology	1	Phase 2	3
DFTX	Definium Therapeutics	Neurology	4	Phase 3	4
DYN	Dyne Therapeutics	MetabolicNeurology Rare	7	NDA Submitted	10
ELDN	Eledon Pharmaceuticals	ImmunologyMetabolic+1 Rare	1	Phase 2	3
EVMN	Evommune	DermatologyImmunology+1	1	Phase 2	5
GANX	Gain Therapeutics	MetabolicNeurology Rare	4	Phase 1	5
GHRS	GH Research	NeurologyWomen's Health	3	Phase 2	4
GRCE	Grace Therapeutics	Neurology	1	NDA Submitted	1
HRMY	Harmony Biosciences	MetabolicNeurology Rare	12	Approved	17
IMUX	Immunic	GI/HepatologyNeurology	2	Phase 3	4
IMVT	Immunovant	ImmunologyNeurology Rare	2	Phase 3	6
IXHL	Incannex Healthcare	ImmunologyNeurology+1	1	Phase 2	3
INSM	Insmed	CardiovascularImmunology+2 Rare	2	Approved	17
IONS	Ionis Pharmaceuticals	CardiovascularHematology+5 Rare	7	Approved	29
KYTX	Kyverna Therapeutics	ImmunologyNeurology+1 Rare	3	NDA Submitted	7
LRMR	Larimar Therapeutics	Neurology Rare	1	NDA Submitted	1
LXEO	Lexeo Therapeutics	CardiovascularNeurology Rare	5	Phase 2	8
LCTX	Lineage Cell Therapeutics	MetabolicNeurology+1 Rare	1	Phase 2	12
LGVN	Longeveron	CardiovascularMetabolic+1 Rare	1	Phase 2	4
MPLT	MapLight Therapeutics	Neurology	4	Phase 2	6
MGTX	MeiraGTx	ImmunologyMetabolic+2 Rare	2	Phase 2	16
NGEN	NervGen Pharma	Neurology	3	Phase 1	3
NGNE	Neurogene	Neurology Rare	1	Phase 3	1
NRSN	NeuroSense Therapeutics	Neurology Rare	3	Phase 2	3
NAMS	NewAmsterdam Pharma	CardiovascularMetabolic+1	1	NDA Submitted	6
NKTX	Nkarta	ImmunologyNeurology+1 Rare	1	Phase 1	8
NRXP	NRX Pharmaceuticals	Neurology Rare	6	NDA Submitted	6
NRIX	Nurix Therapeutics	ImmunologyNeurology+1	1	Phase 3	16
OCS	Oculis Holding	NeurologyOphthalmology Rare	1	Phase 3	4
OMER	Omeros	HematologyNeurology+2 Rare	2	Approved	6
OVID	Ovid Therapeutics	Neurology Rare	3	Phase 2	4
KTTA	Pasithea Therapeutics	NeurologyOncology Rare	2	Phase 1	4
PEPG	PepGen	Neurology Rare	1	Phase 2	1
DTIL	Precision Biosciences	Infectious DiseaseMetabolic+1 Rare	2	Phase 1	5
PCSA	Processa Pharmaceuticals	GI/HepatologyImmunology+2 Rare	1	Phase 2	7
PMN	ProMIS Neurosciences	Neurology Rare	6	Phase 1	6
PRQR	ProQR Therapeutics	MetabolicNeurology Rare	1	Phase 1	7
RLMD	Relmada Therapeutics	MetabolicNeurology+1 Rare	2	Phase 2	4
RVPH	Reviva Pharmaceuticals	CardiovascularDermatology+2 Rare	7	Phase 3	10
SRPT	Sarepta Therapeutics	NeurologyRespiratory Rare	9	Approved	10
SLDB	Solid Biosciences	CardiovascularNeurology Rare	2	Phase 3	6
TSHA	Taysha Gene Therapies	Neurology Rare	3	Phase 3	4
TGTX	Tg Therapeutics	Neurology Rare	6	Approved	6
RARE	Ultragenyx Pharmaceutical	CardiovascularGI/Hepatology+2 Rare	2	Approved	12
QURE	uniQure	HematologyMetabolic+1 Rare	2	Approved	4
VNDA	Vanda Pharmaceuticals	CardiovascularDermatology+6 Rare	16	Approved	27
VKTX	Viking Therapeutics	MetabolicNeurology Rare	1	Phase 3	8
VOR	Vor Biopharma	ImmunologyNeurology Rare	1	Phase 3	2
VYGR	Voyager Therapeutics	MetabolicNeurology Rare	8	Phase 1	9
WVE	Wave Life Sciences	MetabolicNeurology+1 Rare	2	Phase 2	5
XNCR	Xencor	HematologyImmunology+4 Rare	3	Approved	36
XENE	Xenon Pharmaceuticals	Neurology Rare	8	NDA Submitted	9
XERS	Xeris Biopharma	MetabolicNeurology Rare	1	Approved	4
ZBIO	Zenas BioPharma	DermatologyImmunology+2 Rare	3	NDA Submitted	11